About Incyte

Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines to address serious medical conditions. The company's key products include Jakafi, a treatment for myelofibrosis and polycythemia vera, and Pemazyre, a treatment for cholangiocarcinoma. Incyte's research and development efforts aim to improve patient outcomes and quality of life in various therapeutic areas, including oncology and immunology.